Works matching IS 17921074 AND DT 2022 AND VI 23 AND IP 6
Results: 30
Neutrophil infiltration combined with necrosis in the primary tumor is a useful prognostic indicator for three-year disease-free survival time in patients with colorectal cancer.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13320
- By:
- Publication type:
- Article
Role of von Willebrand factor in the angiogenesis of lung adenocarcinoma.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13319
- By:
- Publication type:
- Article
Prognostic significance of the expression levels of T-cell immunoglobulin mucin-3 and its ligand galectin-9 for relapse-free survival in triple-negative breast cancer.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13318
- By:
- Publication type:
- Article
Epigenetic editing and tumor-dependent immunosuppressive signaling in head and neck malignancies.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13317
- By:
- Publication type:
- Article
Simultaneous multiple myeloma and non-small cell lung carcinoma: A case report and review of the literature.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13315
- By:
- Publication type:
- Article
Role of high ubiquitin-conjugating enzyme E2 expression as a prognostic factor in nasopharyngeal carcinoma.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13314
- By:
- Publication type:
- Article
Significance of combined TGF-β1 and survivin expression on the prognosis of patients with triple-negative breast cancer.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13313
- By:
- Publication type:
- Article
Genome maintenance in retinoblastoma: Implications for therapeutic vulnerabilities.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13312
- By:
- Publication type:
- Article
Brain metastasis: Recent treatment modalities and future-perspectives.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13311
- By:
- Publication type:
- Article
Multilevel mechanism of immune checkpoint inhibitor action in solid tumors: History, present issues and future development.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13310
- By:
- Publication type:
- Article
Ki67 for evaluating the prognosis of gastrointestinal stromal tumors: A systematic review and meta-analysis.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13309
- By:
- Publication type:
- Article
Intratumoral expression analysis reveals that OX40 and TIM-3 are prominently expressed and have variable associations with clinical outcomes in high grade serous ovarian cancer.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13308
- By:
- Publication type:
- Article
6-Gingerol suppresses cell viability, migration and invasion via inhibiting EMT, and inducing autophagy and ferroptosis in LPS-stimulated and LPS-unstimulated prostate cancer cells.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13307
- By:
- Publication type:
- Article
hsa_circ_0000523/miR-let-7b/METTL3 axis regulates proliferation, apoptosis and metastasis in the HCT116 human colorectal cancer cell line.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13306
- By:
- Publication type:
- Article
Differential and divergent activity of insulin-like growth factor binding protein 6 in platinum-sensitive versus platinum-resistant high-grade serous ovarian carcinoma cell lines.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13305
- By:
- Publication type:
- Article
Tanshinone IIA inhibits cell growth by suppressing SIX1-induced aerobic glycolysis in non-small cell lung cancer cells.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13304
- By:
- Publication type:
- Article
Tyrosine kinase inhibitors in sarcoma treatment.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13303
- By:
- Publication type:
- Article
Perphenazine and prochlorperazine decrease glioblastoma U-87 MG cell migration and invasion: Analysis of the ABCB1 and ABCG2 transporters, E-cadherin, α-tubulin and integrins (α3, α5, and β1) levels.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13302
- By:
- Publication type:
- Article
Role of STK11 in ALK-positive non-small cell lung cancer.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13301
- By:
- Publication type:
- Article
Artemether inhibits proliferation, invasion and migration of hepatocellular carcinoma cells via targeting of CYP2J2.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13300
- By:
- Publication type:
- Article
All-trans-retinoic acid induces RARB-dependent apoptosis via ROS induction and enhances cisplatin sensitivity by NRF2 downregulation in cholangiocarcinoma cells.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13299
- By:
- Publication type:
- Article
An elemental diet protects mouse salivary glands from 5-fluorouracil-induced atrophy.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13298
- By:
- Publication type:
- Article
3D cell culture alters signal transduction and drug response in head and neck squamous cell carcinoma.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13297
- By:
- Publication type:
- Article
Comparison of different lymph node staging systems for predicting prognosis in patients with colon cancer who have undergone surgical resection.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG
- By:
- Publication type:
- Article
KLF10 upregulates ACSM3 via the PI3K/Akt signaling pathway to inhibit the malignant progression of melanoma.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13295
- By:
- Publication type:
- Article
Downregulation of FTL decreases proliferation of malignant mesothelioma cells by inducing G<sub>1</sub> cell cycle arrest.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13294
- By:
- Publication type:
- Article
Crumbs3 is expressed in oral squamous cell carcinomas and promotes cell migration and proliferation by affecting RhoA activity.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13293
- By:
- Publication type:
- Article
Progress in neoadjuvant therapy for gastric cancer.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13292
- By:
- Publication type:
- Article
Therapy-related acute myeloid leukemia: A case series.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13291
- By:
- Publication type:
- Article
Tepotinib suppresses proliferation, invasion, migration, and promotes apoptosis of melanoma cells via inhibiting MET and PI3K/AKT signaling pathways.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13290
- By:
- Publication type:
- Article